Skip to main content

Thanks to medical research and technology, people live longer than ever before. It is great, but brings challenges as well

The older we become, the greater is the risk of developing cognitive difficulties and in worse case developing degenerative brain diseases. But how do you know if you’re at risk for declining brain health?

BrainSymph AS was founded in 2019 as a spin-off company from the Cognitive Health Research group, Oslo University Hospital. The founders Ira Haraldsen, Christoffer Hatlestad-Hall and Vebjørn Andersson were intrigued by the large discrepancies between state-of-the-art EEG based network analysis techniques and clinical procedures provided in everyday healthcare. Importantly, the theoretical complexity and resource-demanding manual execution of these techniques have long been a barrier to their clinical application. BrainSymph will tear down this barrier.

BrainSymph is committed to delivering large-scale screening of brain pathology, for patients to receive the best diagnostics in an easy-to-access and intuitive framework.